Corporate News Releases

Dr. Roberto Pietro Antonacci Joins Applied Biomedical as Chief Medical Officer and as member of the Scientific Advisory Board

Lake Grove, NY – October 28th, 2024 – Applied Biomedical, a leading innovator in medical biotechnology, is proud to announce the appointment of Roberto Pietro

Applied Biomedical is pleased to announce the appointment of Dean Petkanas as Interim Chief Executive Officer

Dean Petkanas is a corporate finance and executive management professional with over 25 years of investment banking and capital markets experience. In 2010 Mr. Petkanas

Infectious Disease Updates

Global Health Update: WHO Introduces Game-Changing Treatment for Drug-Resistant Tuberculosis

Whole Genome Sequencing Enhances Understanding of Drug-Resistant Tuberculosis

Tuberculosis on the Rise: A Closer Look at the 2024–2025 Kansas Outbreak

Next Generation of Rapid Diagnostics

Applied BioMedical (ABM) is developing the next generation of essential, rapid, point of care diagnostics for infectious disease and oncology

Drug-Resistant Tuberculosis: Elevated Risk Among Military Personnel in the Philippines

Kansas Grapples with Major Tuberculosis Outbreak Amid Public Health Challenges

1 2 3

About

Committed to excellence, we adhere to current Good Manufacturing Practice (cGMP) standards and are preparing for ISO 13485 certification.

Visit at

Facebook-f Twitter Instagram Youtube

Subscribe to Our Newsletter


    MADE BY ELLIPSIS MARKETING